IBD Flashcards

(12 cards)

1
Q

What are 1st line treatments for CD?

A

Mild: Budesonide (Enterocort EC) for ≤3 months –> thiopurine/MTX
Moderate-Severe: Anti-TNF agent +/- MTX/thiopurine, IL rec antagonist; alt. Integrin receptor antagonist, Jak inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 1st line treatments for UC?

A

Mild: Mesalamine (rectal preferred for distal; PO+/- rectal for extensive)
Moderate-severe: Anti-TNF +/- thiopurine, IL rec antagonist, Integrin receptor antagonist
Alt: Jak inhibitor, Oral sphingosin 1phosphate receptor modulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When are recal steroids used?

A

UC only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are CIs/warnings with mesalamine ER?

A

CI: HSR to (amino)salycilates
Warnings: HSR (myocarditis, pericarditis, nephritis, hemotologic abnormalities, organ damage)- More likely with sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which forms of Mesalamine can leave a ghost tablet in the stool?

A

Asacol
Delzicol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is the mesalamine suppository vs. enema administered?

A

Suppository (Canasa): retain for 1-3h
Enema (Rowasa): retain over night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mesalamine ER

A

Pentasa (ER cap)
Asacol HD (ER tab)
Rowasa (enema)
Canasa (suppository)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are BBWs/SEs with azathioprine and mercaptoprine (thiopurines)?

A

BBW: Immunosuppression warnings (azathioprine)
Warnings: Hematologic toxicity; TPMT deficiency increases risk for myelosuppression
SE: N/V/D, rash, elevated LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What agents are Integrin inhibitors used for mod-severe IBD?

A

natalizumab (Tysarbi)
vedolizumab (Entivyo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are BBWs with natalizumab (Tysarbi)?

A
  1. Progressive multifocal leukoencephalopathy (PML)
  2. Only avalible thru REMS TOUCH program
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is natalizumab (Tysarbi) administered/dosed?

A

IV every 4 weeks; D/C if no response in 12 weeks due to PML risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are warnings with vedolizumab (Entyvio)?

A
  1. Infusion reactions
  2. Infections, PML (lower risk than natalizumab)
  3. D/C if no benefit by 14 weeks
  4. hepatic injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly